US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist

8.260
-0.240-2.82%

Close Apr 24 16:00 ET

797.10MMarket Cap-14491P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-97.72%30K

-97.84%10K

-96.98%20K

-76.10%1.32M

189K

464K

663K

Operating revenue

-97.72%30K

--0

-97.84%10K

-96.98%20K

-76.10%1.32M

--0

--189K

--464K

--663K

Cost of revenue

Gross profit

Operating expense

83.40%67.55M

-33.78%10.23M

163.65%17.98M

202.78%20.61M

141.34%18.73M

47.56%36.83M

15.44M

6.82M

6.81M

7.76M

Selling and administrative expenses

156.20%47.28M

-36.44%6.82M

411.83%14.98M

441.29%13.31M

420.78%12.18M

293.77%18.46M

--10.73M

--2.93M

--2.46M

--2.34M

-General and administrative expense

156.20%47.28M

-36.44%6.82M

411.83%14.98M

441.29%13.31M

420.78%12.18M

293.77%18.46M

--10.73M

--2.93M

--2.46M

--2.34M

Research and development costs

10.29%20.27M

-27.73%3.4M

-22.89%3M

68.00%7.31M

20.82%6.55M

-9.36%18.38M

--4.71M

--3.89M

--4.35M

--5.42M

Operating profit

-90.11%-67.52M

33.78%-10.23M

-171.16%-17.98M

-224.76%-20.6M

-163.60%-18.71M

-82.56%-35.52M

-15.44M

-6.63M

-6.34M

-7.1M

Net non-operating interest income expense

Other net income (expense)

1,477.34%13.16M

201.58%3.06M

6,521.28%3.11M

4,353.95%3.23M

2,584.77%3.75M

205.70%834K

1.01M

47K

-76K

-151K

Gain on sale of security

----

---140K

----

Other non- operating income (expenses)

1,250.62%13.16M

164.99%3.06M

6,521.28%3.11M

4,353.95%3.23M

2,584.77%3.75M

223.45%974K

--1.15M

--47K

---76K

---151K

Income before tax

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

-14.43M

-6.58M

-6.42M

-7.25M

Income tax

Net income

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

-14.43M

-6.58M

-6.42M

-7.25M

Net income continuous Operations

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

---14.43M

---6.58M

---6.42M

---7.25M

Minority interest income

Net income attributable to the parent company

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

-14.43M

-6.58M

-6.42M

-7.25M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

-14.43M

-6.58M

-6.42M

-7.25M

Basic earnings per share

34.48%-0.57

54.43%-0.07

-127.91%-0.16

-162.91%-0.18

-106.94%-0.16

-303.00%-0.87

-0.1536

-0.0702

-0.0685

-0.0773

Diluted earnings per share

34.48%-0.57

54.43%-0.07

-127.91%-0.16

-162.91%-0.18

-106.94%-0.16

-303.00%-0.87

-0.1536

-0.0702

-0.0685

-0.0773

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-97.72%30K	0	0	-97.84%10K	-96.98%20K	-76.10%1.32M	0	189K	464K	663K
Operating revenue	-97.72%30K	--0	--0	-97.84%10K	-96.98%20K	-76.10%1.32M	--0	--189K	--464K	--663K
Cost of revenue
Gross profit
Operating expense	83.40%67.55M	-33.78%10.23M	163.65%17.98M	202.78%20.61M	141.34%18.73M	47.56%36.83M	15.44M	6.82M	6.81M	7.76M
Selling and administrative expenses	156.20%47.28M	-36.44%6.82M	411.83%14.98M	441.29%13.31M	420.78%12.18M	293.77%18.46M	--10.73M	--2.93M	--2.46M	--2.34M
-General and administrative expense	156.20%47.28M	-36.44%6.82M	411.83%14.98M	441.29%13.31M	420.78%12.18M	293.77%18.46M	--10.73M	--2.93M	--2.46M	--2.34M
Research and development costs	10.29%20.27M	-27.73%3.4M	-22.89%3M	68.00%7.31M	20.82%6.55M	-9.36%18.38M	--4.71M	--3.89M	--4.35M	--5.42M
Operating profit	-90.11%-67.52M	33.78%-10.23M	-171.16%-17.98M	-224.76%-20.6M	-163.60%-18.71M	-82.56%-35.52M	-15.44M	-6.63M	-6.34M	-7.1M
Net non-operating interest income expense
Other net income (expense)	1,477.34%13.16M	201.58%3.06M	6,521.28%3.11M	4,353.95%3.23M	2,584.77%3.75M	205.70%834K	1.01M	47K	-76K	-151K
Gain on sale of security	----	----	----	----	----	---140K	----	----	----	----
Other non- operating income (expenses)	1,250.62%13.16M	164.99%3.06M	6,521.28%3.11M	4,353.95%3.23M	2,584.77%3.75M	223.45%974K	--1.15M	--47K	---76K	---151K
Income before tax	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	-14.43M	-6.58M	-6.42M	-7.25M
Income tax
Net income	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	-14.43M	-6.58M	-6.42M	-7.25M
Net income continuous Operations	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	---14.43M	---6.58M	---6.42M	---7.25M
Minority interest income
Net income attributable to the parent company	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	-14.43M	-6.58M	-6.42M	-7.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	-14.43M	-6.58M	-6.42M	-7.25M
Basic earnings per share	34.48%-0.57	54.43%-0.07	-127.91%-0.16	-162.91%-0.18	-106.94%-0.16	-303.00%-0.87	-0.1536	-0.0702	-0.0685	-0.0773
Diluted earnings per share	34.48%-0.57	54.43%-0.07	-127.91%-0.16	-162.91%-0.18	-106.94%-0.16	-303.00%-0.87	-0.1536	-0.0702	-0.0685	-0.0773
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall